These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6434264)

  • 1. [Study on "cui xing an" in lowering intraocular pressure and miosis. Part II. Preliminary observation on its therapeutic effect on primary open-angle glaucoma].
    Yang BL
    Zhonghua Yan Ke Za Zhi; 1984 Jan; 20(1):14-8. PubMed ID: 6434264
    [No Abstract]   [Full Text] [Related]  

  • 2. Principles of medical management in chronic open angle glaucoma.
    Sugar HS
    Ann Ophthalmol; 1971 Jun; 3(6):579-86. PubMed ID: 5164431
    [No Abstract]   [Full Text] [Related]  

  • 3. Intraocular pressure-lowering effects of latanoprost monotherapy versus latanoprost or pilocarpine in combination with timolol: a randomized, observer-masked multicenter study in patients with open-angle glaucoma. Italian Latanoprost Study Group.
    Bucci MG
    J Glaucoma; 1999 Feb; 8(1):24-30. PubMed ID: 10084271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studies on ding gong teng in lowering of intraocular pressure and miosis].
    Zhou WB; Peng DW; Chen XQ; Zeng SJ; Qiu PX; Hu BR
    Yan Ke Xue Bao; 1986 Sep; 2(3):150-3. PubMed ID: 2852605
    [No Abstract]   [Full Text] [Related]  

  • 5. [Study on the intraocular pressure reducing and miotic actions of Cui Xing Ning and Cui Xing An (author's transl)].
    Yang BL
    Zhonghua Yan Ke Za Zhi; 1982 Jan; 18(1):5-11. PubMed ID: 6806049
    [No Abstract]   [Full Text] [Related]  

  • 6. [Timolol 0.5%/dorzolamide 2% fixed combination versus timolol 0.5%/pilocarpine 2% fixed combination in primary open-angle glaucoma or ocular hypertensive patients].
    Kałuzny JJ; Szaflik J; Czechowicz-Janicka K; Kałuzny J; Orzałkiewicz A; Zaleska-Zmijewska A; Krajewska M; Stewart JA; Leech JN; Stewart WC
    Klin Oczna; 2004; 106(1-2 Suppl):241-2. PubMed ID: 15510513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glaucoma case report: a nutritional response.
    Veach JE
    Optometry; 2003 Dec; 74(12):775-81. PubMed ID: 14677729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of 0.1% dipivalyl epinephrine and 1% epinephrine in patients with glaucoma or ocular hypertension].
    Shao H; Sun XY; Bai FG
    Zhonghua Yan Ke Za Zhi; 1994 Mar; 30(2):104-7. PubMed ID: 8001439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The modern treatment of glaucoma.
    Perkins ES
    Br J Physiol Opt; 1965; 22(3):133-42. PubMed ID: 5857381
    [No Abstract]   [Full Text] [Related]  

  • 10. The influence of diclofenac ophthalmic solution on the intraocular pressure-lowering effect of topical 0.5% timolol and 0.005% latanoprost in primary open-angle glaucoma patients.
    Costagliola C; Parmeggiani F; Antinozzi PP; Caccavale A; Cotticelli L; Sebastiani A
    Exp Eye Res; 2005 Nov; 81(5):610-5. PubMed ID: 15949795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative analysis of life quality in patients receiving beta-blockers and xalathane (latanoprost)].
    Tugushi OA; Shliapuzhnikova AV; Listopadova NA
    Vestn Oftalmol; 2005; 121(4):41-3. PubMed ID: 16223045
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of the role of travoprost 0.004% ophthalmic solution in the management of open angle glaucoma and ocular hypertensive patients.
    Chiselită D;
    Oftalmologia; 2007; 51(2):81-6. PubMed ID: 17937041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary open angle glaucoma: an overview on medical therapy.
    Vetrugno M; Cantatore F; Ruggeri G; Ferreri P; Montepara A; Quinto A; Sborgia C
    Prog Brain Res; 2008; 173():181-93. PubMed ID: 18929109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long-term effect of domestic timolol on patients with primary open-angle glaucoma].
    Hu C
    Zhonghua Yan Ke Za Zhi; 1984 Jan; 20(1):6-13. PubMed ID: 6434275
    [No Abstract]   [Full Text] [Related]  

  • 15. Nimesulide oral administration increases the intraocular pressure-lowering effect of latanoprost in patients with primary open-angle glaucoma.
    Costagliola C; Parmeggiani F; Caccavale A; Sebastiani A
    Am J Ophthalmol; 2006 Feb; 141(2):379-81. PubMed ID: 16458700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Proxodolol, a new domestic preparation for lowering intraocular pressure in glaucoma].
    Ermakova VN; Iuzhakov SD; Mashkovskiĭ MD; Kolomoĭtseva EM
    Vestn Oftalmol; 1995; 111(2):4-7. PubMed ID: 7645180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, investigator-masked comparison of diurnal responder rates with bimatoprost and latanoprost in the lowering of intraocular pressure.
    Choplin N; Bernstein P; Batoosingh AL; Whitcup SM;
    Surv Ophthalmol; 2004 Mar; 49 Suppl 1():S19-25. PubMed ID: 15016558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy of primary open-angle glaucoma by oftan-dipivefrin].
    Egorov EA; Alekseev VN; Erichev VP; Usachev VV; Simonova SV; Iakubova LV
    Vestn Oftalmol; 2000; 116(1):32-3. PubMed ID: 10741262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of latanoprost and dorzolamide in the treatment of patients with open angle glaucoma.
    Niazi MK; Raja N
    J Ayub Med Coll Abbottabad; 2004; 16(1):50-3. PubMed ID: 15125183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The safety and efficacy of brinzolamide 1%/timolol 0.5% fixed combination versus dorzolamide 2%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension.
    Manni G; Denis P; Chew P; Sharpe ED; Orengo-Nania S; Coote MA; Laganovska G; Volksone L; Zeyen T; Filatori I; James J; Aung T
    J Glaucoma; 2009; 18(4):293-300. PubMed ID: 19365194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.